ArticleClinical lung cancer2024

Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer.

Arpeet T Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.